Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2002
03/27/2002EP1190258A1 Assay for degp protease inhibitors
03/27/2002EP1190257A1 Early detection of flaviviruses using the ns1 glycoprotein
03/27/2002EP1190256A1 Combinatorial library with particle classes that can be distinguished by two features e.g. size, density, color, etc.
03/27/2002EP1190255A1 Epitopes formed by non-covalent association of conjugates
03/27/2002EP1190254A2 Attachment of biomolecule to a polymeric solid support by cycloaddition of a linker
03/27/2002EP1190253A1 Biosensors which utilize charge neutral conjugated polymers
03/27/2002EP1190252A1 Polyionic coatings in analytic and sensor devices
03/27/2002EP1190251A2 Detection of ryanodine receptor antibodies
03/27/2002EP1190250A2 Heparanase assay
03/27/2002EP1190249A2 Compounds and methods to enhance raav transduction
03/27/2002EP1190248A1 Screening methods for compounds which affect melanogenesis
03/27/2002EP1190247A1 Test method for evaluating soluble polymer growth when recycling inhibitor streams
03/27/2002EP1190246A2 Devices and methods for assessing cellular transport for research, drug discovery and testing, clinical diagnoses, and therapy design
03/27/2002EP1190245A1 Allergen detection
03/27/2002EP1190241A2 Microfluidic devices for transverse electrophoresis and isoelectric focusing
03/27/2002EP1190236A1 Sensor platform and method for analysing multiple analytes
03/27/2002EP1190231A1 System for electrochemical quantitative analysis of analytes within a solid phase
03/27/2002EP1190229A2 Microfabricated cell sorter
03/27/2002EP1190097A2 Improved primers and methods for the detection and discrimination of nucleic acids
03/27/2002EP1190096A1 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
03/27/2002EP1190095A2 High throughput assay system
03/27/2002EP1190093A2 Apparatus and process for monitoring and detecting small molecule-biomolecule interactions
03/27/2002EP1190092A2 Fixed address analysis of sequence tags
03/27/2002EP1190090A2 Method to determine the toxicity caused by exposure to chemical and physical agents
03/27/2002EP1190072A2 22012, a novel human carboxypeptidase
03/27/2002EP1190071A2 17867, a novel human aminopeptidase
03/27/2002EP1190070A1 Cyclic amp phosphodiesterase isoforms and methods of use
03/27/2002EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides
03/27/2002EP1190063A1 Nucleic and proteinic acids corresponding to human gene abc1
03/27/2002EP1190061A1 Streptavidin expressed gene fusions and methods of use thereof
03/27/2002EP1190057A1 Cloning and expression of a novel 5-ht4 receptor
03/27/2002EP1190056A1 Human cytokine receptor
03/27/2002EP1190055A2 Human endogenous retrovirus in breast cancer
03/27/2002EP1190054A1 Epithelial cell growth inhibitors
03/27/2002EP1190053A2 Mammalian calcium channels and related probes, cell lines and methods
03/27/2002EP1190052A1 16405 receptor, a g-protein coupled receptor
03/27/2002EP1190051A2 Human transport proteins
03/27/2002EP1190050A2 Human transcriptional regulator proteins
03/27/2002EP1190049A1 Spliceosome protein and its use
03/27/2002EP1190048A2 Novel candida albicans genes and proteins coded by said genes
03/27/2002EP1189967A1 Method of partitioning blood using polyesters
03/27/2002EP1189952A1 Isobutene polymerisation process
03/27/2002EP1189937A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same
03/27/2002EP1189919A1 Assays for apoptosis modulators
03/27/2002EP1189917A1 48 human secreted proteins
03/27/2002EP1189645A2 Non-covalent bioconjugates useful for diagnosis and therapy
03/27/2002EP1189631A1 Neurodegenerative disorder related gene
03/27/2002EP1189629A2 Methods and reagents for treating glucose metabolic disorders
03/27/2002EP1189610A1 Method and markers for prognosticating efficacy of anticancer agents
03/27/2002EP1159614A4 Diagnostic methods for asthma
03/27/2002EP1047454A4 Methods of screening compounds useful for prevention of infection or pathogenicity
03/27/2002EP1023299B1 Combined generation of phosphinic acid derivatives
03/27/2002EP1007534A4 Bh3 interacting domain death agonist
03/27/2002EP0935677B1 Method for preparing assay supports having an ordered set of reaction zones
03/27/2002EP0871936B1 Method for predicting chemical or physical properties of complex mixtures
03/27/2002EP0868702B1 Deconvolution method for the analysis of data resulting from analytical separation processes
03/27/2002EP0782452B1 Cell growth regulator
03/27/2002EP0733123B1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells
03/27/2002EP0547114B1 Microassay on a card
03/27/2002CN2483724Y Apparatus used for detecting biochip
03/27/2002CN2483723Y Real-time quantitative analyser for piezoelectric gene dianostic
03/27/2002CN2483722Y Miniflow detecting apparatus for piezoelectric biochip
03/27/2002CN2483712Y Transparent plastic urine storage bag
03/27/2002CN2483708Y Enclosed excrement sampler
03/27/2002CN1342266A Method and kit for extracting prion protein
03/27/2002CN1342265A Method for quantitating leukocyte count in whole blood sample
03/27/2002CN1342264A Heart abnormalities in vascular endothelial growth factor B(VEGF-B) deficient animals and methods relating to these heart abnormalities
03/27/2002CN1342208A Method for manipulating complex nucleic acid populations using peptide-labeled oligonucleotides
03/27/2002CN1342165A Neurotrophic growth factor
03/27/2002CN1342083A Uses of 1-amino-3-(N,N-dimethylamino)propylidene-1,1-bisphosphonic acid
03/27/2002CN1342080A Use of 5-HT5-ligands in treatment of neurodegenerative and neuropsychiatric disturbances
03/27/2002CN1342070A Binding partners for 5-HT5 receptors for treatment of migraine
03/27/2002CN1341859A Dioxian detection method
03/27/2002CN1341858A Coxsackievirus B immunoglobulin antibody M enzyme immunological kit and its preparation method
03/27/2002CN1341857A Coxsackievirus B immunoglobulin antibody G enzyme immunologic kit and its preparation method
03/27/2002CN1341856A Portable tester
03/27/2002CN1341753A Method for diagnosing and curing dentinogenesis imperfacta type II by using dentin salivary phosphoprotein gene and its coded product
03/27/2002CN1341593A Proteinase inhibitor
03/27/2002CN1341592A Proteinase inhibitor
03/27/2002CN1341590A Proteinase inhibitor
03/27/2002CN1081795C Non-destructive taste characteristic determination device and pallet suitable the same
03/27/2002CN1081792C Automatic process for the maceral analysis and determination of reflectance of vitrinite in coals
03/27/2002CN1081721C Method of assaying compressive strength of rock
03/27/2002CN1081673C Method and agent box for determining gene of hemorrhagic fever viruse of nephropathic syndrome
03/27/2002CN1081611C Detecting method of anion-cation resin transport interface for fine treatment of condensed water
03/26/2002US6363328 Software controlled meat probe for use in determining meat tenderness
03/26/2002US6363313 Fuel property detecting system
03/26/2002US6363290 Interactive control systems for medical processing devices
03/26/2002US6362891 Powder analysis
03/26/2002US6362890 Method and device for checking the liquid take up of a test layer of an analysis element
03/26/2002US6362477 Bulk material analyser for on-conveyor belt analysis
03/26/2002US6362474 Semiconductor sample for transmission electron microscope and method of manufacturing the same
03/26/2002US6362394 Expressing receptor polypeptide in transgenic plant cell; contacting transgenic plant cell with juvenile hormone or its agonists, wherein receptor polypeptide controls expression of target polypeptide in presence of juvenile hormone
03/26/2002US6362371 β2- adrenergic receptor agonists
03/26/2002US6362328 Assays and probes with enzyme labels
03/26/2002US6362327 To provide assays and materials to identify and evaluate pharmacological agents that are potent inhibitors of cyclooxygenase-2 and cyclooxygenase-2 activity
03/26/2002US6362324 Used as target for diagnosis and treatment in aminopeptidase-related disorders such as aging, cancers, cataracts, cystic fibrosis and leukemias; used in drug-screening to identify agonists, antagonists
03/26/2002US6362317 Sensitivity
03/26/2002US6362316 Human metabotropic glutamate receptor subtype mGluR6 protein
03/26/2002US6362229 Inhibitors of multidrug transporters